Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guideline update: adjuvant therapy for triple negative breast cancer in 2022
@article{TBCR63878, author = {Hua Ding and Li Zhang and Yue Wang and Shu Liu}, title = {Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guideline update: adjuvant therapy for triple negative breast cancer in 2022}, journal = {Translational Breast Cancer Research}, volume = {3}, number = {0}, year = {2022}, keywords = {}, abstract = {}, issn = {2218-6778}, url = {https://tbcr.amegroups.org/article/view/63878} }